Session Type: Poster Session (Tuesday)
Session Time: 9:00AM-11:00AM
Background/Purpose: Patients may hold negative perceptions towards biosimilars which can create barriers to their uptake. Physicians also report uncertainty in how best to explain biosimilars. The aim of this study was to measure the effect of differently framed explanations on patients’ perceptions of and willingness to switch to a biosimilar.
Methods: Ninety-six patients with rheumatic diseases taking an originator biologic were randomised to receive one of four biosimilar explanations delivered by video- positive framing with and without an analogy, and negative framing with and without an analogy. The same physician was featured in each video explanation to ensure consistency.. The positive explanation employed a positive valence attribute frame, whereby the similarities between the biologic and biosimilar were emphasised. The physician featured in the video used positive body language and verbal cues (e.g. nodding and smiling) to promote a positive interaction. Comparatively, the negatively framed explanation focused on the differences between biologics and biosimilars, and the physician used negative body language and verbal cues (e.g. less confident vocal tone) to imply uncertainty regarding efficacy and safety. The analogy used focused on the concept of baking bread, using a cheaper yeast from a different brand. Willingness to switch to a biosimilar, perceptions about biosimilars, and the effectiveness of the explanation were measured after the information delivery.
Results: Positive framing led to more participants being willing to switch (67%) than negative framing (46%). Framing significantly predicted willingness to switch to a biosimilar, with participants in the positive framing group being 2.36 times more willing to switch (P = 0.041). The positive framing group also reported significantly greater perceived efficacy of biosimilars (P = 0.046), and thought the explanation was more convincing (P = 0.030). The analogy did not enhance willingness to switch or understanding (P > 0.05).
Conclusion: Positive framing can improve perceptions of and willingness to switch to a biosimilar in patients currently taking biologic medications.
To cite this abstract in AMA style:Gasteiger C, Jones A, Kleinstauber M, Lobo M, Horne R, Petrie K, Dalbeth N. The Effects of Message Framing on Patients’ Perceptions and Willingness to Switch to a Biosimilar [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-effects-of-message-framing-on-patients-perceptions-and-willingness-to-switch-to-a-biosimilar/. Accessed May 11, 2021.
« Back to 2019 ACR/ARP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-message-framing-on-patients-perceptions-and-willingness-to-switch-to-a-biosimilar/